December 2021

Dr. Romero-Sandoval received a medical degree from Centro Universitario de Occidente, Quetzaltenango (Universidad de San Carlos de Guatemala) in 1999 and a Ph.D. degree in Neuroscience from Universidad de Alcalá de Henares, Spain, in 2003. He completed postdoctoral training at Wake Forest University, Winston Salem, NC (2003-2006) and Geisel Dartmouth Medical School, Lebanon, NH […]

November 2021

Professor Bryan is an internationally renowned social and health psychologist known for her research on HIV/STD prevention, exercise promotion, healthy eating, and most recently, the public health implications of legalized cannabis. She is a Professor and Associate Chair for Faculty Development in the Department of Psychology and Neuroscience at the University of Colorado Boulder […]

October 2021

Dr. Susan Weiss is the Director, Division of Extramural Research at the National Institute on Drug Abuse (NIDA), which oversees NIDA’s extramural programs, operations planning, and trans-NIH initiatives, such as the Adolescent Brain Cognitive Development (ABCD®) and HEALthy Brain Child Development (HBCD) studies, and the Brain Research through Advancing Innovative Neurotechnologies® (BRAIN) Initiative. Dr. […]

September 2021

Gillian Schauer, PhD, MPH, is the Executive Director of the Cannabis Regulators Association (CANNRA) and a Senior Consultant on cannabis policy, epidemiology, and research translation. Her consulting has included work with the U.S. Centers for Disease Control and Prevention, the National Institute on Drug Abuse, and a number of U.S. states. Dr. Schauer is […]

July 2021

Dr. Ziva Cooper is the Director of the UCLA Cannabis Research Initiative in the Jane and Terry Semel Institute for Neuroscience and Human Behavior and Associate Professor in the Department of Psychiatry and Biobehavioral Sciences and Department of Anesthesiology at the David Geffen School of Medicine. Her current research involves understanding variables that influence […]

June 2021

Dr. Clayton W. Snell is the Senior Medical Science Liaison at Greenwich Biosciences (now part of Jazz Pharmaceuticals) and holds a Doctor of Pharmacy (PharmD) from the University of the Sciences in Philadelphia and possesses experience in professional medical affairs, healthcare services, and a demonstrated history in the pharmaceutical industry.

Dr. Clayton W. Snell, Cannabis […]

May 2021

George Hodgin

Title: Access to Federally Compliant Cannabis for Research
George Hodgin is the Founder and CEO of Biopharmaceutical Research Company (BRC), an applicant with the Drug Enforcement Administration to produce federally compliant cannabis products for research. BRC holds several DEA Schedule I Registrations and engages in compliant cannabis research. He is a former Navy SEAL […]

April 2021

The Institute of Cannabis Research’s monthly webinar for April 2021 featured Dr. Cristina Sempio. Dr. Sempio is a Research Instructor in the Department of Anesthesiology at the University of Colorado Anschutz Medical Campus. She earned her PhD in forensic sciences at the University of Verona (Italy), developing cutting-edge analytical methods for the screening and quantification of […]

March 2021

The Institute of Cannabis Research’s monthly webinar for March 2021 featured Dr. Sara Jane Ward. She is the Assistant Professor from Temple University. Her research focuses on the behavioral pharmacological effects of the cannabinoid, serotonin, and opioid receptor systems on neuropathic pain and neuroprotection, learning and memory, and addiction. Her research makes use of rodent […]

February 2021

The Institute of Cannabis Research’s monthly webinar for February 2021 featured Dr. Ashley Brooks-Russell from The University of Colorado Anschutz Medical Campus. Dr. Brooks-Russell is an assistant professor and Director of the Program for Injury Prevention, Education and Research Program at the Colorado School of Public Health, CU Anschutz. She completed her Ph.D. in Health […]